Compare · MDLN vs NXGL
MDLN vs NXGL
Side-by-side comparison of Medline Inc. (MDLN) and NexGel Inc (NXGL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NXGL operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.96B, about 8677.9x NXGL ($5.4M).
- Over the past year, MDLN is down 17.5% and NXGL is down 73.0% - MDLN leads by 55.5 points.
- MDLN has been more active in the news (21 items in the past 4 weeks vs 12 for NXGL).
- MDLN has more recent analyst coverage (25 ratings vs 1 for NXGL).
PerformanceMDLN-17.53%NXGL-68.56%
2025-12-17+0.00%2026-06-02
- Company
- Medline Inc.
- NexGel Inc
- Price
- $33.60-6.12%
- $0.59-2.81%
- Market cap
- $46.96B
- $5.4M
- 1M return
- -24.92%
- -1.59%
- 1Y return
- -17.53%
- -73.03%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 21
- 12
- Recent ratings
- 25
- 1
NXGL
NexGel Inc
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest NXGL
- Chief Executive Officer Levy Adam R. sold $7,834 worth of shares (13,000 units at $0.60), decreasing direct ownership by 4% to 344,692 units (SEC Form 4)
- SEC Form PRE 14A filed by NexGel Inc
- NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
- SEC Form 4 filed by Director Henry Scott Robert
- SEC Form 4 filed by Director Kieser Brian Joseph
- SEC Form 4 filed by Chief Executive Officer Levy Adam R.
- SEC Form 3 filed by new insider Harris Kevin Mcclain
- SEC Form 3 filed by new insider Kieser Brian Joseph
- SEC Form 10-Q filed by NexGel Inc
- NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical